{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Carbendazim",
  "nciThesaurus": {
    "casRegistry": "10605-21-7",
    "chebiId": "",
    "chemicalFormula": "C9H9N3O2",
    "definition": "A broad-spectrum benzimidazole antifungal with potential antimitotic and antineoplastic activities. Although the exact mechanism of action is unclear, carbendazim appears to binds to an unspecified site on tubulin and suppresses microtubule assembly dynamic. This results in cell cycle arrest at the G2/M phase and an induction of apoptosis.",
    "fdaUniiCode": "H75J14AA89",
    "identifier": "C1154",
    "preferredName": "Carbendazim",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C67421"
    ],
    "synonyms": [
      "1H-Benzimidazol-2-yl-carbamic Acid, Methyl Ester",
      "1H-benzimidazol-2-ylcarbamic Acid Methyl Ester",
      "2-(Methoxycarbonylamino)benzimidazole",
      "2-Benzimidazolecarcamic Acid Methyl Ester",
      "2-Methyl benzimidazolecarbamate",
      "BAS 3460",
      "BAS-3460",
      "BAS-67054",
      "BCM",
      "BMC",
      "Bavistin",
      "CARBENDAZIM",
      "CTR 6669",
      "CTR-6669",
      "Carbendazim",
      "Carbendazole",
      "Derosal",
      "FB642",
      "HOE 17411",
      "HOE-17411",
      "MBC",
      "Methyl 2-Benzimidazolecarbamate",
      "Methyl 2-benzimidazolecarbamate",
      "Methyl Benzimidazol-2-ylcarbamate",
      "Methyl-1H-benzimidazol-2-yl Carbamate",
      "Methyl-2-benzimidazole Carbamate",
      "Methyl-2-benzimidazolecarbamate",
      "Methyl-alpha-benzimidazole Carbamate",
      "carbendazim"
    ]
  }
}